Scientists develop method to examine HIV drugs' structure

01/31/2010 | Reuters

A team of U.S. and British researchers created a crystal to further examine the 3-D structure of HIV drugs from Merck & Co. and Gilead Sciences and how they bind to and inhibit the integrase enzyme. The crystal, which was grown from an integrase found in a retrovirus similar to HIV, could help improve HIV medicines and prevent drug resistance, according to the study.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Senior Manager, Compliance
Stryker
Fremont, CA
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA